Skip to content
OpenCapital
Get started

West Pharmaceutical Services WST Proprietary Products — Net Sales

Other segment segments

West Vantage
$150.6M—

Similar metrics at other companies

AVT
AVTRProprietary — Net Sales
$833.3M+0.4%
Aquestive Therapeutics, Inc. logo
AQSTProprietary product revenue, net — Revenue
$0-100%
Grow Generation logo
GRWGProprietary brand sales — Net Sales
$11.8M+19.4%
Mirum Pharmaceuticals, Inc. logo
MIRMProduct sales, net — Product sales, net
$159.88M+43.3%
XER
XERSProduct revenue, net — Product revenue, net
$82.45M+42.6%
AptarGroup logo
ATRPharma — Net Sales
$438.91M+7.1%

Other financials

Income statement

See full
Revenue$844.9M+21.0%
Gross profit$296.4M+27.8%
Operating income$177.1M+65.5%
Net income$138.8M+54.6%
EPS (diluted)$1.92+56.1%

Balance sheet

See full
Cash & equivalents$521.4M+29.0%
Total debt$321.0M+4.4%
Total equity$3.0B+11.5%
Total assets$4.1B+13.6%

Cash flow

See full
Operating cash flow$89.9M-30.5%
CapEx$42.7M-40.1%
Free cash flow$47.2M-18.8%

Valuation

See full
Market cap$25.36B+64.2%
Enterprise value$25.16B+65.1%
P/E46.7×+15.1×
P/S7.9×+2.7×

Profitability

See full
Gross margin36.3%+1.7pp
Operating margin20.3%+1.2pp
Net margin16.8%+0.7pp
FCF margin14.2%+3.6pp

Returns & leverage

See full
Return on equity19.1%+1.7pp
Debt / equity0.1×0.0×
Current ratio2.7×-0.1×

Where this comes from

Reported directly by West Pharmaceutical Services in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: West Pharmaceutical Services’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about West Pharmaceutical Services's proprietary products — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is West Pharmaceutical Services's proprietary products — net sales?
West Pharmaceutical Services (WST) reported proprietary products — net sales of $694.3M in Q1 2026.
How has West Pharmaceutical Services's proprietary products — net sales changed year-over-year?
West Pharmaceutical Services's proprietary products — net sales increased by 23.3% year-over-year, from $563M to $694.3M.
What is the long-term trend for West Pharmaceutical Services's proprietary products — net sales?
Over 2 years (2023 to 2025), West Pharmaceutical Services's proprietary products — net sales has grown at a 2.0% compound annual growth rate (CAGR), from $2.4B to $2.49B.
What does proprietary products — net sales mean?
This metric represents the total revenue generated from the sale of proprietary pharmaceutical packaging and delivery components. It reflects the market demand for the company's specialized, high-margin products within the pharmaceutical and biotechnology sectors.